Stockreport

AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]

AIM ImmunoTech Inc.  (AIM) 
PDF – Driving significant momentum with positive clinical trial data, underscoring big pharma collaboration and commercialization opportunities – Company to host conferen [Read more]